Implantation or Injectable Dosage Form New Animal Drugs; Xylazine Injection
other · US Department of Health and Human Services · Rule · Published 1996-09-04 · Effective 1996-09-04 · 61 FR 46548
Document
Document number
96-22487
Federal Register citation
61 FR 46548
CFR reference
21 CFR 522
Type
Rule
Action
Final rule.
Category
other
Sub-agency
US Department of Health and Human Services
Publication date
1996-09-04
Effective date
1996-09-04
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of an abbreviated new animal drug application (ANADA) filed by Chanelle Pharmaceuticals Manufacturing Ltd. The ANADA provides for intravenous, intramuscular, or subcutaneous use of xylazine injection in dogs and cats to produce sedation accompanied by a shorter period of analgesia.